Tag: Myocardial Solutions

PREFECT Trial Outcomes Demonstrate MyoStrain® Ability to Detect & Predict Early Cardiotoxicity in Cancer Patients Undergoing Chemotherapy

Coronary/Structural Heart by 0 comments

MORRISVILLE, N.C., June 23, 2021 /PRNewswire/ — A new pivotal article validated Myocardial Solutions technology MyoStrain® (fSENC) for the early detection and prediction of cardiotoxicity (heart damage). The article was published in Circulation: Cardiovascular Imaging and highlights MyoStrain as an accurate and sensitive management tool […]

Continue Reading →

MyoStrain® Provides Comprehensive Assessment of Myocardial Deformation to Help Physicians Risk-Stratify Heart Failure Patients for Individualized Cardiac Treatment

Coronary/Structural Heart by 0 comments

MyoStrain provided a uniquely sensitive and reproducible measure of segmental heart function to help physicians quantify differences in heart failure patients and risk-stratify patient populations based on the individual extent and severity of dysfunction MORRISVILLE, N.C., April 19, 2021 /PRNewswire/ — A new […]

Continue Reading →

New Rapid Cardiac MR Imaging Helps Detect and Manage Patient Heart Health During and After Cancer Treatments

Radiology Regulatory by 0 comments

United Imaging now preferred medical imaging partner for MyoStrain® and its unique diagnostic cardiac test. HOUSTON, Aug. 5, 2020 /PRNewswire/ — United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, along with Myocardial Solutions, a medical technology company working […]

Continue Reading →